Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metastatic Non-Squamous Non-Small Cell Lung Cancer × sitravatinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Metastatic Non-Squamous Non-Small Cell Lung Cancer 1 Lung Diseases 1 Esophageal Squamous Cell Carcinoma 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Advanced or Metastatic Solid Malignancies 1 Advanced Malignancies 1 Adenocarcinoma 1

Interventions

Nivolumab 2 Docetaxel 2 sitravatinib 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03906071 2025-10-21

SAPPHIRE

Mirati Therapeutics Inc.

Phase 3 Completed

577 enrolled 22 charts

Metastatic Non-Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡